Tokyo Tape
Sign in
← BrightPath Biotherapeutics

Annual report

4594.TEDINET S100ODEX
Period2021-04-01 → 2022-03-31
Filed2022-06-23
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed

Amended by S100PTK6 (2022-12-19).

Key figures · 82
MetricValuePeriodScopeSource row
Revenue¥15m2021-04-01 → 2022-03-31StandaloneNet sales
Revenue¥3m2020-04-01 → 2021-03-31StandaloneNet sales
Revenue¥11m2019-04-01 → 2020-03-31dStandaloneNet sales (5-year summary)
Revenue¥156m2018-04-01 → 2019-03-31dStandaloneNet sales (5-year summary)
Revenue¥354m2017-04-01 → 2018-03-31dStandaloneNet sales (5-year summary)
Operating income−¥1.5bn2021-04-01 → 2022-03-31StandaloneOperating income
Operating income−¥1.7bn2020-04-01 → 2021-03-31StandaloneOperating income
Ordinary income−¥1.5bn2021-04-01 → 2022-03-31StandaloneOrdinary income
Ordinary income−¥1.7bn2020-04-01 → 2021-03-31StandaloneOrdinary income
Ordinary income−¥1.8bn2019-04-01 → 2020-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥1.7bn2018-04-01 → 2019-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥1.6bn2017-04-01 → 2018-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥1.6bn2017-04-01 → 2018-03-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax−¥1.5bn2021-04-01 → 2022-03-31StandaloneIncome before income taxes
Profit before tax−¥1.7bn2020-04-01 → 2021-03-31StandaloneIncome before income taxes
Net income (owners)−¥1.6bn2017-04-01 → 2018-03-31dStandaloneProfit loss attributable to owners of parent (5-year summary)
Net income−¥1.5bn2021-04-01 → 2022-03-31StandaloneProfit loss
Net income−¥1.7bn2020-04-01 → 2021-03-31StandaloneProfit loss
Net income−¥1.9bn2019-04-01 → 2020-03-31dStandaloneNet income loss (5-year summary)
Net income−¥1.9bn2018-04-01 → 2019-03-31dStandaloneNet income loss (5-year summary)
Net income−¥1.6bn2017-04-01 → 2018-03-31dStandaloneNet income loss (5-year summary)
Total assets¥2.8bnat 2022-03-31StandaloneAssets
Total assets¥3.7bnat 2021-03-31StandaloneAssets
Total assets¥3.5bnat 2020-03-31dStandaloneTotal assets (5-year summary)
Total assets¥5.3bnat 2019-03-31dStandaloneTotal assets (5-year summary)
Total assets¥7.2bnat 2018-03-31dStandaloneTotal assets (5-year summary)
Total assets¥7.2bnat 2018-03-31dStandaloneTotal assets (5-year summary)
Total liabilities¥240mat 2022-03-31StandaloneLiabilities
Total liabilities¥212mat 2021-03-31StandaloneLiabilities
Net assets / equity¥2.5bnat 2022-03-31StandaloneNet assets
Net assets / equity¥3.5bnat 2021-03-31StandaloneNet assets
Net assets / equity¥3.2bnat 2020-03-31dStandaloneNet assets
Net assets / equity¥5.1bnat 2019-03-31dStandaloneNet assets (5-year summary)
Net assets / equity¥7.0bnat 2018-03-31dStandaloneNet assets (5-year summary)
Cash and deposits¥2.3bnat 2022-03-31StandaloneCash and deposits
Cash and deposits¥3.3bnat 2021-03-31StandaloneCash and deposits
Cash & equivalents¥2.3bnat 2022-03-31StandaloneCash and cash equivalents
Cash & equivalents¥3.3bnat 2021-03-31StandaloneCash and cash equivalents
Cash & equivalents¥3.0bnat 2020-03-31dStandaloneCash and cash equivalents
Cash & equivalents¥4.9bnat 2019-03-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥6.5bnat 2018-03-31dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow−¥1.5bn2021-04-01 → 2022-03-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥1.8bn2020-04-01 → 2021-03-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥1.8bn2019-04-01 → 2020-03-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥1.5bn2018-04-01 → 2019-03-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥1.6bn2017-04-01 → 2018-03-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥18m2021-04-01 → 2022-03-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥36m2020-04-01 → 2021-03-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥107m2019-04-01 → 2020-03-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥185m2018-04-01 → 2019-03-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥112m2017-04-01 → 2018-03-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow¥569m2021-04-01 → 2022-03-31StandaloneNet cash provided by used in financing activities
Financing cash flow¥2.1bn2020-04-01 → 2021-03-31StandaloneNet cash provided by used in financing activities
Financing cash flow¥9m2019-04-01 → 2020-03-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥16m2018-04-01 → 2019-03-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥3.3bn2017-04-01 → 2018-03-31dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥-28.552021-04-01 → 2022-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-36.142020-04-01 → 2021-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-44.22019-04-01 → 2020-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-44.952018-04-01 → 2019-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-41.252017-04-01 → 2018-03-31dStandaloneBasic earnings loss per share (5-year summary)
Net assets per share¥45.4at 2022-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥69.1at 2021-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥75.49at 2020-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥119.66at 2019-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥164.78at 2018-03-31dStandaloneNet assets per share (5-year summary)
Equity ratio90.5%at 2022-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio93.7%at 2021-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio91.5%at 2020-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio94.7%at 2019-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio95.3%at 2018-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio95.2%at 2018-03-31dStandaloneEquity to asset ratio (5-year summary)
Shares issued55,253,100at 2022-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued50,817,500at 2021-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued42,101,000at 2020-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued41,993,500at 2019-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued41,835,400at 2018-03-31dStandaloneTotal number of issued shares (5-year summary)
Employees38at 2022-03-31StandaloneNumber of employees
Employees44at 2021-03-31StandaloneNumber of employees
Employees44at 2020-03-31dStandaloneNumber of employees
Employees42at 2019-03-31dStandaloneNumber of employees
Employees42at 2018-03-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 803
ItemContextValueUnit
Net assetsPrior1YearInstant_NonConsolidatedMember3537642000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember2531475000JPY
Liabilities and net assetsPrior1YearInstant_NonConsolidatedMember3749428000JPY
Liabilities and net assetsCurrentYearInstant_NonConsolidatedMember2771202000JPY
Net salesPrior1YearDuration_NonConsolidatedMember2504000JPY
Net salesCurrentYearDuration_NonConsolidatedMember15408000JPY
Research and development costsPrior1YearDuration_NonConsolidatedMember1145000JPY
Research and development costsCurrentYearDuration_NonConsolidatedMember102000JPY
Cost of other sales cosPrior1YearDuration_NonConsolidatedMember－JPY
Cost of other sales cosCurrentYearDuration_NonConsolidatedMember3215000JPY
Cost of salesPrior1YearDuration_NonConsolidatedMember1145000JPY
Cost of salesCurrentYearDuration_NonConsolidatedMember3317000JPY
Gross profitPrior1YearDuration_NonConsolidatedMember1358000JPY
Gross profitCurrentYearDuration_NonConsolidatedMember12091000JPY
Selling general and administrative expensesPrior1YearDuration_NonConsolidatedMember1734161000JPY
Selling general and administrative expensesCurrentYearDuration_NonConsolidatedMember1488124000JPY
Operating incomePrior1YearDuration_NonConsolidatedMember-1732802000JPY
Operating incomeCurrentYearDuration_NonConsolidatedMember-1476033000JPY
Interest income noiPrior1YearDuration_NonConsolidatedMember35000JPY
Interest income noiCurrentYearDuration_NonConsolidatedMember27000JPY
Foreign exchange gains noiPrior1YearDuration_NonConsolidatedMember3131000JPY
Foreign exchange gains noiCurrentYearDuration_NonConsolidatedMember－JPY
Other noiPrior1YearDuration_NonConsolidatedMember98000JPY
Other noiCurrentYearDuration_NonConsolidatedMember89000JPY
Non operating incomePrior1YearDuration_NonConsolidatedMember3265000JPY
Non operating incomeCurrentYearDuration_NonConsolidatedMember117000JPY
Interest on bonds noePrior1YearDuration_NonConsolidatedMember－JPY
Interest on bonds noeCurrentYearDuration_NonConsolidatedMember362000JPY
Foreign exchange losses noePrior1YearDuration_NonConsolidatedMember－JPY
Foreign exchange losses noeCurrentYearDuration_NonConsolidatedMember3470000JPY
Stock issuance cost noePrior1YearDuration_NonConsolidatedMember9099000JPY
Stock issuance cost noeCurrentYearDuration_NonConsolidatedMember2197000JPY
Miscellaneous loss noePrior1YearDuration_NonConsolidatedMember0JPY
Miscellaneous loss noeCurrentYearDuration_NonConsolidatedMember－JPY
Non operating expensesPrior1YearDuration_NonConsolidatedMember9099000JPY
Non operating expensesCurrentYearDuration_NonConsolidatedMember6029000JPY
Ordinary incomePrior1YearDuration_NonConsolidatedMember-1738636000JPY
Ordinary incomeCurrentYearDuration_NonConsolidatedMember-1481945000JPY
Gain on reversal of subscription rights to shares eiPrior1YearDuration_NonConsolidatedMember31051000JPY
Gain on reversal of subscription rights to shares eiCurrentYearDuration_NonConsolidatedMember5899000JPY
Gain on sales of noncurrent assets eiPrior1YearDuration_NonConsolidatedMember－JPY
Gain on sales of noncurrent assets eiCurrentYearDuration_NonConsolidatedMember13000JPY
Extraordinary incomePrior1YearDuration_NonConsolidatedMember31051000JPY
Extraordinary incomeCurrentYearDuration_NonConsolidatedMember5912000JPY
Impairment loss elPrior1YearDuration_NonConsolidatedMember9629000JPY
Impairment loss elCurrentYearDuration_NonConsolidatedMember5701000JPY
Other elPrior1YearDuration_NonConsolidatedMember0JPY
Other elCurrentYearDuration_NonConsolidatedMember37000JPY
Extraordinary lossPrior1YearDuration_NonConsolidatedMember9629000JPY
Extraordinary lossCurrentYearDuration_NonConsolidatedMember5738000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 13 of 13 passed
balance sheet identitynon_consolidated 2021-03-31pass rounding
balance sheet identitynon_consolidated 2022-03-31pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2020-03-31pass
statement vs summary · net assetsnon_consolidated 2021-03-31pass
statement vs summary · net assetsnon_consolidated 2022-03-31pass
statement vs summary · operating cash flownon_consolidated 2020-04-01/2021-03-31pass
statement vs summary · operating cash flownon_consolidated 2021-04-01/2022-03-31pass
statement vs summary · revenuenon_consolidated 2020-04-01/2021-03-31pass
statement vs summary · revenuenon_consolidated 2021-04-01/2022-03-31pass
statement vs summary · total assetsnon_consolidated 2021-03-31pass
statement vs summary · total assetsnon_consolidated 2022-03-31pass